{"id":481639,"date":"2020-04-28T18:00:01","date_gmt":"2020-04-28T18:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=481639"},"modified":"2020-04-28T18:00:01","modified_gmt":"2020-04-28T18:00:01","slug":"pharmaceutical-robots-market-worth-usd-11946-million-by-2021-growing-at-a-cagr-of-132","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharmaceutical-robots-market-worth-usd-11946-million-by-2021-growing-at-a-cagr-of-132_481639.html","title":{"rendered":"Pharmaceutical Robots Market Worth USD 119.46 million by 2021, Growing at a CAGR of 13.2%"},"content":{"rendered":"
\"Pharmaceutical<\/a><\/p>\n
\n
Key players considered in the analysis of the pharmaceutical robotic systems market are Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland)<\/div>\n<\/div>\n<\/div>\n
Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications)<\/div>\n

Robotic systems provide various benefits to pharmaceutical manufacturing such as lesser space utilization, reduced production downtime, no labor turnover, enhanced health and safety, better waste management, increased production flexibility, improved production output and product quality, and lower operating costs.<\/p>\n

Pharmaceutical Robots Market<\/a> by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) – Global Forecast to 2021
<\/strong>
The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021<\/strong>. Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.<\/p>\n

Request Sample Pages:<\/strong> https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=210985096<\/a><\/p>\n

The Global pharmaceutical robotic systems market is Segmented on:
<\/strong>
1. Type
2. Application<\/p>\n

Benefits offered by robotic systems in pharmaceutical manufacturing drive the global pharmaceutical robotic systems market
<\/strong>
In 2015, the U.S. FDA approved 45 new medicines as compared to 27 in 2013. It also approved 98% of high-risk medical devices in 2014 as compared to 86% in 2013 and 70% in 2012. As the demand for new drugs and medicines grows, pharmaceutical companies are continuously looking for new ways to increase productivity, leading to an increased reliance on automated equipment and robotics.<\/p>\n

A robotic system is a type of automation that has multiple axes of motion and can be programmed to perform a function<\/strong>. Some of the benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability and reproducibility, and in cleanrooms, removing the potential for human contamination.<\/p>\n

On the basis of application, the global pharmaceutical robotic systems market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications.<\/strong> The picking and packaging segment accounted for the largest share of the global pharmaceutical robotic systems market.<\/p>\n

Download PDF Brochure:<\/strong> 
https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=210985096<\/a><\/p>\n

Regional Analysis:
<\/strong>
The pharmaceutical robotic systems market in APAC is expected to grow at the highest CAGR during the forecast period owing to factors such as the increase in domestic industrial robots companies, flourishing pharmaceutical industry<\/strong>, increasing number of conferences and exhibitions, investments and funding in the industrial robots industry, and Japan’s Robot Strategy.<\/p>\n

Key Players:
<\/strong>
Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A\/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Sanjay Gupta
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/pharmaceutical-robot-market-210985096.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Key players considered in the analysis of the pharmaceutical robotic systems market are Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland) Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,416],"tags":[],"class_list":["post-481639","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/481639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=481639"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/481639\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=481639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=481639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=481639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}